These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8807874)

  • 41. The scope of antibody catalysis.
    Jacobsen JR; Schultz PG
    Curr Opin Struct Biol; 1995 Dec; 5(6):818-24. PubMed ID: 8749371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The interplay between binding energy and catalysis in the evolution of a catalytic antibody.
    Ulrich HD; Mundorff E; Santarsiero BD; Driggers EM; Stevens RC; Schultz PG
    Nature; 1997 Sep; 389(6648):271-5. PubMed ID: 9305839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Catalytic antibody activity elicited by active immunisation. Evidence for natural variation involving preferential stabilization of the transition state.
    Gallacher G; Jackson CS; Searcey M; Goel R; Mellor GW; Smith CZ; Brocklehurst K
    Eur J Biochem; 1993 May; 214(1):197-207. PubMed ID: 8508792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding and catalysis: a thermodynamic study on a catalytic antibody system.
    Wade H; Scanlan TS
    Chembiochem; 2003 Jun; 4(6):537-40. PubMed ID: 12794866
    [No Abstract]   [Full Text] [Related]  

  • 45. Structural basis of the transition-state stabilization in antibody-catalyzed hydrolysis.
    Sakakura M; Takahashi H; Shimba N; Fujii I; Shimada I
    J Mol Biol; 2007 Mar; 367(1):133-47. PubMed ID: 17239396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crystal structures of the free and liganded form of an esterolytic catalytic antibody.
    Wedemayer GJ; Wang LH; Patten PA; Schultz PG; Stevens RC
    J Mol Biol; 1997 May; 268(2):390-400. PubMed ID: 9159478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA hydrolysis by monoclonal autoantibody BV 04-01.
    Rodkey LS; Gololobov G; Rumbley CA; Rumbley J; Schourov DV; Makarevich OI; Gabibov AG; Voss EW
    Appl Biochem Biotechnol; 2000; 83(1-3):95-103; discussion 103-5, 145-53. PubMed ID: 10826952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Localization of protease activity in antibody subunits.
    Sun M; Li L; Gao QS; Paul S
    Ann N Y Acad Sci; 1995 Sep; 764():573-5. PubMed ID: 7486588
    [No Abstract]   [Full Text] [Related]  

  • 49. A suicide-substrate mechanism for hydrolysis of beta-lactams by an anti-idiotypic catalytic antibody.
    Lefevre S; Debat H; Thomas D; Friboulet A; Avalle B
    FEBS Lett; 2001 Jan; 489(1):25-8. PubMed ID: 11231007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Theoretical investigation of the origins of catalysis of a retro-Diels-Alder reaction by antibody 10F11.
    Leach AG; Houk KN; Reymond JL
    J Org Chem; 2004 May; 69(11):3683-92. PubMed ID: 15152997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An antibody exo Diels-Alderase inhibitor complex at 1.95 angstrom resolution.
    Heine A; Stura EA; Yli-Kauhaluoma JT; Gao C; Deng Q; Beno BR; Houk KN; Janda KD; Wilson IA
    Science; 1998 Mar; 279(5358):1934-40. PubMed ID: 9506943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Peculiarities of the Mechanism of Interactions of Catalytic Antibodies with Organophosphorus Substrates].
    Mokrushina YA; Pipiya SO; Stepanova AV; Shamborant OG; Knorre VD; Smirnov IV; Gabibov AG; Vorobiev II
    Mol Biol (Mosk); 2017; 51(6):958-968. PubMed ID: 29271960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Routes to catalysis: structure of a catalytic antibody and comparison with its natural counterpart.
    Haynes MR; Stura EA; Hilvert D; Wilson IA
    Science; 1994 Feb; 263(5147):646-52. PubMed ID: 8303271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficient and selective p-nitrophenyl-ester-hydrolyzing antibodies elicited by a p-nitrobenzyl phosphonate hapten.
    Tawfik DS; Lindner AB; Chap R; Eshhar Z; Green BS
    Eur J Biochem; 1997 Mar; 244(2):619-26. PubMed ID: 9119032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression and characterization of recombinant single-chain Fv and Fv fragments derived from a set of catalytic antibodies.
    Kim SH; Schindler DG; Lindner AB; Tawfik DS; Eshhar Z
    Mol Immunol; 1997; 34(12-13):891-906. PubMed ID: 9464525
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Completing the circle.
    Schultz PG; Lerner RA
    Nature; 2002 Aug; 418(6897):485. PubMed ID: 12152057
    [No Abstract]   [Full Text] [Related]  

  • 57. Catalysis of decarboxylation by a preorganized heterogeneous microenvironment: crystal structures of abzyme 21D8.
    Hotta K; Lange H; Tantillo DJ; Houk KN; Hilvert D; Wilson IA
    J Mol Biol; 2000 Oct; 302(5):1213-25. PubMed ID: 11183784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A modelling study of a non-concerted hydrolytic cycloaddition reaction by the catalytic antibody H11.
    Clark RL; Johnston BF; Suckling CJ; Mackay SP
    Bioorg Med Chem; 2006 Apr; 14(8):2674-83. PubMed ID: 16378728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Remarkable remote chiral recognition in a reaction mediated by a catalytic antibody.
    D'Souza LJ; Gigant B; Knossow M; Green BS
    J Am Chem Soc; 2002 Mar; 124(10):2114-5. PubMed ID: 11878955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis.
    Wentworth P; Liu Y; Wentworth AD; Fan P; Foley MJ; Janda KD
    Proc Natl Acad Sci U S A; 1998 May; 95(11):5971-5. PubMed ID: 9600901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.